Renaissance Capital LLC Bridge Bio Pharma, Inc. Transaction History

Renaissance Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$7.34 - $17.16 $315,429 - $737,433	-42,974 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$11.38 - $53.41 $93,873 - $440,579	-8,249 Reduced 16.1%	42,974 $717,000
Q3 2021 Feb 01, 2022	SELL	$46.87 - $64.24 $3.55 Million - $4.87 Million	-75,814 Reduced 59.68%	51,223 $2.4 Million
Q2 2021 Feb 01, 2022	SELL	$46.47 - $63.93 $59,063 - $81,255	-1,271 Reduced 0.99%	127,037 $7.74 Million
Q1 2021 Feb 01, 2022	BUY	$55.47 - $72.35 $7.12 Million - $9.28 Million	128,308 New	128,308 $7.9 Million

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Renaissance Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Capital LLC with notifications on news.